Author: DelveInsight Business Research LLP

Posted Date:

January 30, 2026

Chronic Hepatitis D Market Poised for Significant Growth During the Forecast Period (2025-2034) as Emerging Therapies Drive Optimism | DelveInsight

DelveInsight Business Research LLP

January 30, 2026
DUB Inhibitors Market to Witness Strong Expansion Across 7MM by 2040 Driven by the Launch of Novel Therapeutics | DelveInsight

DelveInsight Business Research LLP

January 29, 2026
Pharma Conference Coverage Services: Real-Time Pharma Intelligence to Power Strategic Decision-Making

DelveInsight Business Research LLP

January 28, 2026
RET Fusion Targeted Therapies Market Set for Robust Growth by 2034 Amid Precision Oncology Shift | DelveInsight

DelveInsight Business Research LLP

January 28, 2026
Gastroesophageal Reflux Disease Market in the US to Show Promising Growth at a CAGR of 6% During the Forecast Period (2025-2034) | DelveInsight

DelveInsight Business Research LLP

January 27, 2026
Cystinosis Market to Grow at a Substantial Growth Rate of 5.1% During the Forecast Period (2025-2034) | DelveInsight

DelveInsight Business Research LLP

January 27, 2026
PSMA-Targeted Therapy Market Set to Expand by 2034 on Strong Pipeline and Increasing Diagnosis Rates | DelveInsight

DelveInsight Business Research LLP

January 27, 2026
Underactive Bladder Syndrome Market to Observe Stunning Growth at a CAGR of 22.1% During the Forecast Period (2025-2034) | DelveInsight

DelveInsight Business Research LLP

January 26, 2026